115M117M

CeriBell outlines $115M-$117M 2026 revenue, while launching delirium monitoring and previewing Omni for 2027 (NASDAQ:CBLL)

Earnings Call Insights: CeriBell, Inc. (CBLL) Q3 2026

Management View

  • CEO Xingjuan Chao highlighted Q3 growth and commercial execution, saying, “Q3 marked another strong quarter for CeriBell as we delivered revenue of $29.3 million, growing approximately 30% year-over-year.” She tied the quarter to two core drivers: “adoption

Seeking Alpha’s Disclaimer: This article was automatically generated by an AI tool based on content available on the Seeking Alpha website, and has not been curated or reviewed by humans. Due to inherent limitations in using AI-based tools, the accuracy, completeness, or timeliness of such articles cannot be guaranteed. This article is intended for informational purposes only. Seeking Alpha does not take account of your objectives or your financial situation and does not offer any personalized investment advice. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank.

Source link